NEUROCRINE BIOSCIENCES INC Annual Net Cash Provided by (Used in) Financing Activities in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Neurocrine Biosciences Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to 2023.
  • Neurocrine Biosciences Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $69.9M, a 752% increase year-over-year.
  • Neurocrine Biosciences Inc annual Net Cash Provided by (Used in) Financing Activities for 2023 was $65.3M.
  • Neurocrine Biosciences Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$234M, a 955% decline from 2021.
  • Neurocrine Biosciences Inc annual Net Cash Provided by (Used in) Financing Activities for 2021 was $27.4M.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $65.3M +$300M Jan 1, 2023 Dec 31, 2023 10-K 2024-02-09
2022 -$234M -$262M -955% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-09
2021 $27.4M +$185M Jan 1, 2021 Dec 31, 2021 10-K 2024-02-09
2020 -$158M -$190M -587% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-09
2019 $32.4M +$2.9M +9.83% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-11
2018 $29.5M -$487M -94.3% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-05
2017 $517M +$514M +21517% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-07
2016 $2.39M Jan 1, 2016 Dec 31, 2016 10-K 2019-02-08
2013 $5.3M -$78.4M -93.7% Jan 1, 2013 Dec 31, 2013 10-K 2014-02-11
2012 $83.7M +$83.4M +29166% Jan 1, 2012 Dec 31, 2012 10-K 2014-02-11
2011 $286K -$21.2M -98.7% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-11
2010 $21.5M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.